A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year

Transplantation

Volumn 88, Issue 6, 2009, Pages 803-809

  Hernández, Domingo ^a   Sánchez Fructuoso, Ana ^b   González Posada, José Manuel ^a   Arias, Manuel ^c   Campistol, Josep María ^d   Rufino, Margarita ^a   Morales, José María ^e   Moreso, Francesc ^f   Pérez, Germán ^a   Torres, Armando ^a   Serón, Daniel ^f  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Kidney transplantation; Mortality; Prognostic index.

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; COMORBIDITY; CONTROL GROUP; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DIALYSIS; DYSLIPIDEMIA; FEMALE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RISK; RISK FACTOR;

ADULT; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TIME FACTORS; YOUNG ADULT;

EID: 70350536860     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b4ac2f     Document Type: Article

References (23)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl 3): S112.
2. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001; 72(suppl 6): S5.
3. Hernandez D, Rufino M, Bartolomei S, et al. A novel prognostic index for mortality in renal transplant recipients after hospitalisation. Transplantation 2005; 79: 337.
4. Jassal SV, Schaubel DE, Fenton SS. Baseline comorbidity in kidney transplant recipients: A comparison of comorbidity indices. Am J Kidney Dis 2005; 46: 136.
5. Jassal SV, Schaubel DE, Fenton SS. Predicting mortality after kidney transplantation: A clinical tool. Transpl Int 2005; 18: 1248.
6. Wu C, Evans I, Joseph R, et al. Comorbid conditions in kidney transplantation: Association with graft and patient survival. J Am Soc Neph-rol 2005; 16: 3437.
7. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Transplantation 2003; 75(10 suppl): SS3.
8. Hosmer DW, Lemeshow S, May S, eds. Applied survival analysis (ed. 2). Hoboken, NJ: Wiley 2008
9. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 2004; 23: 2109.
10. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373.
11. Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588.
12. González-Posada JM, Hernández D, Genís BB, et al. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain. Clin Transplant 2006; 20: 650.
13. Maluf DG, Fisher RA, King AL, et al. Hepatitis C virus infection and kidney transplantation: Predictors of patient and graft survival. Transplantation 2007; 83: 853.
14. Arango J, Arbelaez M, Henao J, et al. Kidney graft survival in patients with hepatitis C: A single center experience. Clin Transplant 2008; 22: 16.
15. Fernández-Fresnedo G, Escallada R, Rodrigo E, et al. The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation 2002; 73: 1345.
16. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291.
17. Soveri I, Holdaas H, Jardine A, et al. Renal transplant dysfunction-importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.Nephrol Dial Transplant 2006; 21: 2282.
18. Srinivas TR, Kaplan B, Schold JD, et al. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation 2005; 80(2 suppl): S211.
19. Artz MA, Boots JM, Ligtenberg G, et al. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant 2004; 4: 937.
20. Gonzalez Molina M,SeronD, Garcia del Moral R,et al. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Groupof Chronic Allograft Nephropathy. Transplantation 2004; 77: 215.
21. Shihab FS, Waid TH, Conti DJ, et al. Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study. Transplantation 2008; 85: 1261.
22. Hiremath S, Fergusson D, Doucette S, et al. Renin angiotensin system blockadein kidney transplantation: A systematic reviewof the evidence Am J Transplant 2007; 7: 2350.
23. Strippoli GF, Navaneethan SD, Johnson DW, et al. Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials. Brit Med J 2008; 336: 645.